Skip to content
DraconiticResearch
Search Sources API
203,203 studies31 sourcesUpdated 5 min ago
PreprintCC BY-NC-NDmedRxiv

Persistent Fibromyalgia-like symptom presentation in Long COVID-associated chronic musculoskeletal pain: a longitudinal cohort study

  1. 1Leeds Institute of Rheumatic and Musculoskeletal Medicine, School of Medicine, Faculty of Health and Life Sciences, University of Leeds, Leeds, UK

Abstract

BackgroundChronic musculoskeletal pain (CMP) is a common and debilitating symptom of Long COVID (LC), which shares several clinical features with Fibromyalgia Syndrome (FMS).

AimsThis longitudinal study investigated whether the symptom overlap between LC-CMP and FMS persists over time, whether patterns differ according to pre-COVID CMP history, and the extent to which neuropathic pain features are present.

MethodsIndividuals with LC completed questionnaires assessing the symptom-based component of the 2010 American College of Rheumatology criteria for FMS and the presence of neuropathic pain features (PainDetect Questionnaire, PDQ) at baseline, 6- and 12-month follow-ups. Participants were grouped according to pre-COVID CMP history. Group differences were analysed using mixed-effects logistic regression.

Results240 individuals completed the baseline assessment at a mean of 2.61 years after LC onset, including 131 (100 females) with new-onset CMP and 94 (87 females) with pre-existing CMP. The prevalence of participants meeting the symptom-based criteria for FMS remained high across follow-up (67.5-78.6%), with 50.0-61.0% of those with complete follow-up data fulfilling criteria at all timepoints. No significant subgroup differences were observed (OR = 0.43, 95% CI [0.14 1.39], p = 0.160). Across follow-up, 22.2-36.1% of participants reported likely neuropathic pain features, with significantly higher odds in the pre-existing CMP group (OR = 3.17, 95% CI [1.22 8.18], p = 0.017).

ConclusionsFMS-like symptoms remain highly prevalent several years after acute COVID-19 and persist over a further 12 months, suggesting that LC-CMP frequently represents a persistent long-term condition with substantial overlap with FMS. These findings support closer integration of LC and chronic pain rehabilitation services and add to the wider literature linking post-infectious processes with FMS-like symptoms.

Related

  1. Longitudinal Transcriptomic Analysis Identifies Persistent Immune-Related Signature Associated With Restrictive Left Ventricular Filling Patterns After Heart Transplantation
    Kosuke Takahari, Tatsuya Shiraki, Hidetaka Kioka +14
    Circulation JournalPeer-reviewedCC BY-NC-NDFull text3 citedSurgery & anaesthesiaJ-STAGE
  2. Area-Level Rurality and Documented Musculoskeletal Symptom Presentation at Rheumatoid Arthritis Diagnosis Among Older Adults in Rural Japan: A Cross-Sectional Study.
    Ryuichi Ohta, Kunihiro Ichinose, Chiaki Sano
    Healthcare (Basel, Switzerland)Peer-reviewedCC BYFull textGeneral medicineEurope PMC
  3. A reproducible symptom-based computational phenotyping framework for longitudinal fibromyalgia analysis using real-world registry data: a cross-cohort validation study.
    Nazario Felix-Gonzalez, Jose-Maria Gomez-Arguelles, Ceferino Maestu-Unturbe
    BMC medical informatics and decision makingPeer-reviewedCC BYFull textPsychiatry & mental healthEurope PMCPMC
  4. Fermented dairy intake and markers of musculoskeletal ageing on the island of Ireland: insights from the Northern Ireland Cohort for the Longitudinal Study of Ageing (NICOLA) and The Irish Longitudinal Study on Ageing (TILDA)
    Dominic N. Farsi, Nicola A. Ward, Charlotte E. Sterling +6
    European Journal of NutritionPeer-reviewedCC BY 4.0Full textPhysiologyPMC
  5. Persistent prefectural ordering of billed urinary albumin quantification in Japan: a nationwide longitudinal ecological study
    Yoshitaka Furuto
    Diabetology internationalPeer-reviewedLicence not statedFull textEndocrinology & metabolismPMC
BibTeX
@misc{silvapassadouro2026persistent,
  title = {{Persistent Fibromyalgia-like symptom presentation in Long COVID-associated chronic musculoskeletal pain: a longitudinal cohort study}},
  author = {B. Silva-Passadouro and I. Delis and S. L. Astill and C. Brown and A. J. Casson and M. Sivan},
  howpublished = {medRxiv},
  year = {2026},
  month = oct,
  doi = {10.64898/2026.10.07.26364942},
  url = {https://www.medrxiv.org/content/10.64898/2026.10.07.26364942v1},
  note = {CC BY-NC-ND},
}
RIS
TY  - UNPB
TI  - Persistent Fibromyalgia-like symptom presentation in Long COVID-associated chronic musculoskeletal pain: a longitudinal cohort study
AU  - B. Silva-Passadouro
AU  - I. Delis
AU  - S. L. Astill
AU  - C. Brown
AU  - A. J. Casson
AU  - M. Sivan
PY  - 2026
DA  - 2026/10/07
PB  - medRxiv
DO  - 10.64898/2026.10.07.26364942
UR  - https://www.medrxiv.org/content/10.64898/2026.10.07.26364942v1
AB  - BackgroundChronic musculoskeletal pain (CMP) is a common and debilitating symptom of Long COVID (LC), which shares several clinical features with Fibromyalgia Syndrome (FMS).  AimsThis longitudinal study investigated whether the symptom overlap between LC-CMP and FMS persists over time, whether patterns differ according to pre-COVID CMP history, and the extent to which neuropathic pain features are present.  MethodsIndividuals with LC completed questionnaires assessing the symptom-based component of the 2010 American College of Rheumatology criteria for FMS and the presence of neuropathic pain features (PainDetect Questionnaire, PDQ) at baseline, 6- and 12-month follow-ups. Participants were grouped according to pre-COVID CMP history. Group differences were analysed using mixed-effects logistic regression.  Results240 individuals completed the baseline assessment at a mean of 2.61 years after LC onset, including 131 (100 females) with new-onset CMP and 94 (87 females) with pre-existing CMP. The prevalence of participants meeting the symptom-based criteria for FMS remained high across follow-up (67.5-78.6%), with 50.0-61.0% of those with complete follow-up data fulfilling criteria at all timepoints. No significant subgroup differences were observed (OR = 0.43, 95% CI [0.14 1.39], p = 0.160). Across follow-up, 22.2-36.1% of participants reported likely neuropathic pain features, with significantly higher odds in the pre-existing CMP group (OR = 3.17, 95% CI [1.22 8.18], p = 0.017).  ConclusionsFMS-like symptoms remain highly prevalent several years after acute COVID-19 and persist over a further 12 months, suggesting that LC-CMP frequently represents a persistent long-term condition with substantial overlap with FMS. These findings support closer integration of LC and chronic pain rehabilitation services and add to the wider literature linking post-infectious processes with FMS-like symptoms.
ER  -